Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP201313.RAfvIwaI9ShmxJ_vsKN_nny7_Aoy3Al3NdrYclf0gXanc130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP201313.RAfvIwaI9ShmxJ_vsKN_nny7_Aoy3Al3NdrYclf0gXanc130_provenance.
• NP226717.RAqNyPsxCWAm4sCLgmc7YdH4VkarIl55yE-BKRFFN7-5s130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226717.RAqNyPsxCWAm4sCLgmc7YdH4VkarIl55yE-BKRFFN7-5s130_provenance.
• NP618741.RAraynoOVlY7sYYS6AN8pGlD0uulpn_FJn_WJEU1NZdIg130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618741.RAraynoOVlY7sYYS6AN8pGlD0uulpn_FJn_WJEU1NZdIg130_provenance.
• NP170234.RAgcuMVAr2lY-WeWXKw-8bLSrkmvaBrExJimHwTihhxDU130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170234.RAgcuMVAr2lY-WeWXKw-8bLSrkmvaBrExJimHwTihhxDU130_provenance.
• NP571603.RACenT0aTEIcbMqxShAsuV3GlLvfpGyUV2_cOwu6QbH78130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571603.RACenT0aTEIcbMqxShAsuV3GlLvfpGyUV2_cOwu6QbH78130_provenance.
• NP662301.RArWi-QZWEImqkDFBHqt3SYlTOT2iymDESe2hc3dt7h4I130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662301.RArWi-QZWEImqkDFBHqt3SYlTOT2iymDESe2hc3dt7h4I130_provenance.
• NP699349.RAuCnsTNPuYcCg9ge_TXcQJysJxIBj39I9o5-1FRFq44c130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699349.RAuCnsTNPuYcCg9ge_TXcQJysJxIBj39I9o5-1FRFq44c130_provenance.
• NP847897.RAy4mTNnq56EnaY9Cg3koKqlk3OY5A3fltIFBreqJGhqI130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847897.RAy4mTNnq56EnaY9Cg3koKqlk3OY5A3fltIFBreqJGhqI130_provenance.
• NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_provenance.
• NP903539.RAGTQx-SDymv-cX0PT8K3w6wtiimqc2cBbmAZoGZ5DxD4130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903539.RAGTQx-SDymv-cX0PT8K3w6wtiimqc2cBbmAZoGZ5DxD4130_provenance.
• assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP504991.RA-NP2W40vrDFIlJyYqIYwcsUyiwDMZ4i7dnvhqRyP6nY130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504991.RA-NP2W40vrDFIlJyYqIYwcsUyiwDMZ4i7dnvhqRyP6nY130_provenance.
• NP504986.RAaw-rLKkUxI9BTETTyWdCp_AZu0B2fmsH22XGkgHGtVY130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504986.RAaw-rLKkUxI9BTETTyWdCp_AZu0B2fmsH22XGkgHGtVY130_provenance.
• NP504990.RAX2UN3aPreBarlhK_x2JO-ToJ3sTVb7uZ4dZgdGWr-8k130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504990.RAX2UN3aPreBarlhK_x2JO-ToJ3sTVb7uZ4dZgdGWr-8k130_provenance.
• NP504992.RAdN4H627G_jZG3QP0MHPtJT_lHTOZWhcZl7sr1UMwThc130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504992.RAdN4H627G_jZG3QP0MHPtJT_lHTOZWhcZl7sr1UMwThc130_provenance.
• NP504995.RAUbNBTX879MS8l8FlNTGaw0rlPj8mlPsKR8Q5bR6W87g130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504995.RAUbNBTX879MS8l8FlNTGaw0rlPj8mlPsKR8Q5bR6W87g130_provenance.
• NP387238.RAGlOONKpZcqd04iI3TpwYYLf0OQxa_LBn4C80V1HFLUs130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387238.RAGlOONKpZcqd04iI3TpwYYLf0OQxa_LBn4C80V1HFLUs130_provenance.
• NP387297.RAG0P2Sg-sa0S_d9GFqqD5SdOOQmsyP8hlpRj-OfEKpAE130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387297.RAG0P2Sg-sa0S_d9GFqqD5SdOOQmsyP8hlpRj-OfEKpAE130_provenance.
• NP387402.RAPAv0FjWYQYjP_hWl7uwlw07YMfOhdVnkIoQQsC2VdSo130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387402.RAPAv0FjWYQYjP_hWl7uwlw07YMfOhdVnkIoQQsC2VdSo130_provenance.
• assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP504988.RAOEr6GDRBEbY4FAIBl_aD4DwY0bZrpq71i-lfeY2CyMU130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504988.RAOEr6GDRBEbY4FAIBl_aD4DwY0bZrpq71i-lfeY2CyMU130_provenance.
• NP387258.RAkL_ur003tW1rNtae5AFXyUnp_VND1UTL2P9s1Nq6fqw130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387258.RAkL_ur003tW1rNtae5AFXyUnp_VND1UTL2P9s1Nq6fqw130_provenance.
• NP504989.RAkLSd3nBDhBsX7Gbk_1ouuCbNnguHCWw5jLFot9HtziQ130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504989.RAkLSd3nBDhBsX7Gbk_1ouuCbNnguHCWw5jLFot9HtziQ130_provenance.
• NP504993.RAsBmxAuF1FhiCn_JvNXVuhmQlCyOondQkBkBImYSGSO4130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504993.RAsBmxAuF1FhiCn_JvNXVuhmQlCyOondQkBkBImYSGSO4130_provenance.